Home Site Map Make Your Home Page Suggestions Enquiry Advertise With Us
Friday, February 10, 2012  
 
 
News Home
Video News
Press Releases
Features
Events
Special Articles
   
  News Updated on Friday, February 10, 2012 1:37:07 AM
   Find Us on Facebook    Follow Us
» India » Asia » World » Sports » Business » Sci-Tec » Health » Entertainment » Bollywood » Picture Gallery
 
 India

New drug target may help treat chronic rhinosinusitis with polyps
Washington | November 23, 2009 4:11:52 PM IST
 

 

 

Johns Hopkins researchers have identified a protein that is responsible for causing chronic rhinosinusitis with polyps.

Chronic sinusitis, a constant irritation and swelling of the nasal passages, is a common condition thought to affect about one out of every six people. This problem has several forms with a range of severities.

One of the most severe forms produces polyps, overgrowths of unhealthy sinus tissue that can block the nose and sinus passages and make breathing through the nose difficult or impossible. This often results in pain, swelling, and an increase in infections.

Researchers have identified a protein called vascular endothelial growth factor, or VEGF, responsible for the cell overgrowth in the development of polyps.

"This type of sinusitis isn't subtle-you can spot the patients with polyps from across the room. They're breathing through their mouths, they talk with nasal voices, they're constantly sniffling, and their faces are swollen," said Dr Jean Kim, assistant professor in the Departments of Otolaryngology and Allergy and Clinical Immunology at the Johns Hopkins University School of Medicine, and a researcher at the Johns Hopkins Allergy and Asthma Centre at the Johns Hopkins Bayview Medical Centre.

"Once the patient has entered the cycle of growing polyps, it's very hard to get out," she added.

The researchers have long studied sinusitis, often growing sinus cells isolated from patients in petri dishes. After noticing that cells from patients with polyps typically multiplied faster than cells from normal patients, the researchers speculated that cells from polyp patients might be producing extra amounts of some type of growth factor, a protein that encourages cell growth.

To identify which growth factor might be to blame, the researchers had sinusitis patients with and without polyps rinse their sinus passages with a wash solution, then tested the runoff for the presence of various growth factors.

They found that solution from patients with polyps contained high amounts of a substance called vascular endothelial growth factor, or VEGF, a protein important for normal blood vessel growth that also seems to play a key role in a variety of diseases, including cancer.

The more VEGF they found in a cell culture, the faster those cells grew.

"It's a strong indicator that VEGF is indeed responsible for the over-exuberant cell growth that contributes to polyp development," Kim said.

The study appears in American Journal of Respiratory and Critical Care Medicine. (ANI)

 
  Viewer's Comment
Comments Not Available
 
 More Stories

Norwegian dies in Jaipur 

High Court opines against casual ordering of FIRs by lower courts  

EC censures Salman Khurshid over sub-quota issue 

Rajasthan cricket association owes Rs.4.5 crore to police 

Karishma makes upset in junior badminton 

Need to amend laws in coop sector: Gadkari 

K'taka government to celebrate Shivaji Jayanti as govt programme 

Centre urged to make Kerala the 'World Centre of Ayurveda' 


Print this Page
Printer Friendly Version
SocialTwist Tell-a-Friend

Search Archives :  



Quick Links - Webindia123.com
Services
Health
Hobbies
Entertainment
Classifieds
Career / Education
UK, USA, Canada
Utilities
E-Booking
India Reference
 
 
 
 
 
Personalities
 
 
 
 
IndianStates
Punjab
 
Rajasthan
 
Sikkim
 
  
Tripura
 
 
 
 
Pondicherry

Copyright 2000-2012 Suni Systems (P) Ltd.
All rights reserved